论文部分内容阅读
Norplant~R是联合国人口理事会对左旋18甲基炔诺酮皮下埋植剂的注册商标。是目前第一个用于计划生育的皮下埋植药物缓慢释放系统。我中心从1990年5月开始使用Norplant~R埋植剂。已接受对象762例,其中166例观察期满一年。结果报告如下。 1 材料和方法 1.1 制剂Norplant~R系统人口理事会提供芬兰来乐药厂生产的埋植剂。它由六根细小的硅橡胶管囊组成,每根管囊含左旋18-甲基炔诺酮36 mg,埋植后药物通过
Norplant ~ R is a registered trademark of the United Nations Population Council for levonorgestrel 18 implants. Is the first slow-release system for subcutaneous implanted drugs for family planning. My Center since May 1990 began using Norplant ~ R implants. 762 cases have been accepted, of which 166 cases expire one year. The results are reported below. 1 Materials and methods 1.1 Formulation Norplant ~ R system Population Council to provide the Finland Lile pharmaceutical plant implants. It consists of six tiny silicone rubber tube capsule, each tube containing 18-nor-norethindrone 36 mg, after drug implantation